|
Advanced Cell Technology, Inc. announced today that Dr. Robert Lanza will be a featured speaker at the 71st annual meeting of the American College of Rheumatology and the 42nd annual meeting of the Association of Rheumatology Health Professionals scheduled to be will held from November 6th to 11th at the new Boston Convention and Exhibition Center in Boston
LOS ANGELES, CA, USA | November 6, 2007 | Advanced Cell Technology, Inc. (OTCBB: ACTC – News) announced today that Dr. Robert Lanza, M.D., the company’s Chief Scientific Officer, will be a featured speaker at the 71st annual meeting of the American College of Rheumatology and the 42nd annual meeting of the Association of Rheumatology Health Professionals scheduled to be will held from November 6th to 11th at the new Boston Convention and Exhibition Center in Boston.
The ACR Annual Meeting is the rheumatology industry’s leading conference, with over 14,000 scientists and attendees expected. Dr. Lanza will be delivering a presentation titled “The Use of Embryonic Stem Cells in Regenerative Medicine.”
During the presentation, Dr. Lanza is expected to discuss the company’s single biopsy technology that was recently identified by the Department of Health and Human Services as one of the technologies that merits further evaluation for potential financial support.
About Advanced Cell Technology, Inc.
Advanced Cell Technology, Inc. is a biotechnology company applying cellular technology in the emerging field of regenerative medicine. The company operates facilities in California and Massachusetts.
For more information, visit www.advancedcell.com.
Forward-Looking Statements
Statements in this news release regarding future financial and operating results, future growth in research and development programs, potential applications of our technology, opportunities for the company and any other statements about the future expectations, beliefs, goals, plans, or prospects expressed by management constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements that are not statements of historical fact (including statements containing the words “will,” “believes,” “plans,” “anticipates,” “expects,” “estimates,” and similar expressions) should also be considered to be forward-looking statements. There are a number of important factors that could cause actual results or events to differ materially from those indicated by such forward-looking statements, including: limited operating history, need for future capital, risks inherent in the development and commercialization of potential products, protection of our intellectual property, and economic conditions generally. Additional information on potential factors that could affect our results and other risks and uncertainties are detailed from time to time in the company’s periodic reports, including the report on Form 10-QSB for the quarter ended June 30, 2007. Forward-looking statements are based on the beliefs, opinions, and expectations of the company’s management at the time they are made, and the company does not assume any obligation to update its forward-looking statements if those beliefs, opinions, expectations, or other circumstances should change.
Forward-looking statements are based on the beliefs, opinions, and expectations of the company’s management at the time they are made, and the company does not assume any obligation to update its forward-looking statements if those beliefs, opinions, expectations, or other circumstances should change.
Contact:
SOURCE: Advanced Cell Technology, Inc. |
